Showing results (451-460 of 503) with videos related to
Sort By:
Pageof 51
Clinical and Experimental Dermatology|January 13, 2026
Long-Term Effectiveness of Bimekizumab in Plaque Psoriasis: Two-Year Drug Survival from a Real-Life Multicenter Italian StudyEleonora De Luca, Annunziata Dattola, Fabio Artosi, et al.Journal of Clinical Medicine|May 28, 2022
Sharing Patient and Clinician Experiences of Moderate-to-Severe Psoriasis: A Nationwide Italian Survey and Expert Opinion to Explore Barriers Impacting upon Patient WellbeingFrancesca Prignano, Alexandra M G Brunasso, Gabriella Fabbrocini, et al.Photodermatology, Photoimmunology & Photomedicine|January 18, 2021
Italian expert-based recommendations on the use of photo(chemo)therapy in the management of mycosis fungoides: Results of an e-Delphi consensusVieri Grandi, Antonello Baldo, Emilio Berti, et al.Dermatology Practical & Conceptual|March 30, 2026
CORONATE: A Novel Questionnaire to Assess the Long-Term Impact of Psoriasis on Patients' LivesStefano Piaserico, Francesca Sampogna, Martina Accorinti, et al.The Journal of Dermatology|April 16, 2025
Effectiveness of Dupilumab and Omalizumab in Bullous Pemphigoid: A Nationwide Retrospective Cohort StudyGianluca Avallone, Carlo Alberto Maronese, Martina Zussino, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|September 23, 2025
Effectiveness and safety of baricitinib in severe alopecia areata: 48-week resultsBianca Maria Piraccini, Stephano Cedirian, Francesca Pampaloni, et al.Italian Journal of Dermatology and Venereology|May 29, 2024
Italian National Registry of Alopecia Areata: an epidemiological study of 699 Italian patientsBianca Maria Piraccini, Luca Rapparini, Federico Quadrelli, et al.Expert Opinion on Biological Therapy|November 20, 2020
Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 Pandemic: Risk analysis from the PSO-BIO-COVID observational studyMarina Talamonti, Marco Galluzzo, Andrea Chiricozzi, et al.Clinical and Experimental Dermatology|November 1, 2025
Cumulative clinical benefits of biologic treatments in patients with moderate-to-severe psoriasis: an Italian real-life experience - IL PSO (Italian Landscape Psoriasis)Diego Orsini, Luca Potestio, Maria Concetta Fargnoli, et al.Journal of Clinical Medicine|January 11, 2024
Understanding Barriers Impacting upon Patient Wellbeing: A Nationwide Italian Survey and Expert Opinion of Dermatologists Treating Patients with Moderate-to-Severe PsoriasisFrancesca Prignano, Giuseppe Argenziano, Federico Bardazzi, et al.Pageof 51